Loading…

A replacement approach to rodent model for the toxicity evaluation of gram-positive autogenous vaccine

The Abnormal Toxicity Test (ATT) is an in vivo assay traditionally used in the autogenous vaccine release. That test, commonly applied to verify vaccine quality, is subject to ethical and practical limitations and should be removed as reference methods. This approach is necessary to update the regul...

Full description

Saved in:
Bibliographic Details
Published in:Research in veterinary science 2024-11, Vol.180, p.105443, Article 105443
Main Authors: Checco, Martina Angela, Villa, Riccardo, Cacciamali, Andrea, Dotti, Silvia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Abnormal Toxicity Test (ATT) is an in vivo assay traditionally used in the autogenous vaccine release. That test, commonly applied to verify vaccine quality, is subject to ethical and practical limitations and should be removed as reference methods. This approach is necessary to update the regulatory framework and to apply the 3Rs principle in the pharmaceutical field. In this study, two in vitro cell viability assays were used to evaluate the potential toxicity of autogenous vaccines. Cells were treated with base-2 dilutions of autogenous vaccines, and viability was detected by MTT and ATP assays. Differences and similarities between these tests were analysed. The ATP test showed good cell viability at 1:32 or 1:64 vaccine dilutions. The MTT assay gave discordant results and vaccines were not cytotoxic from the first dilutions. For this reason, a preference has been highlighted for the ATP method, a more sensitive test, capable of providing more accurate results. •The in vitro assays could be a replacement tool for the ATT test.•The ATP assay represents the most suitable system to assess cell viability.•In vitro tests are useful for the release process of autogenous vaccines.
ISSN:0034-5288
1532-2661
1532-2661
DOI:10.1016/j.rvsc.2024.105443